New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these symptoms in animal models of the disease.
J&J proposes $6.5B talc settlement plan
Johnson & Johnson has proposed another bankruptcy plan that would settle tens of thousands of talc lawsuits for about $6.5 billion. Faced with mounting allegations